Number of items: 1.
2024
Corbacioglu, Selim ,
Lode, Holger,
Ellinger, Susanne,
Zeman, Florian,
Suttorp, Meinolf,
Escherich, Gabriele,
Bochennek, Konrad,
Gruhn, Bernd,
Lang, Peter,
Rohde, Marius,
Debatin, Klaus Michael,
Steinbach, Daniel,
Beilken, Andreas,
Ladenstein, Ruth,
Spachtholz, Rainer,
Heiss, Peter,
Hellwig, Dirk ,
Tröger, Anja,
Koller, Michael ,
Menhart, Karin ,
Riemenschneider, Markus J. ,
Zoubaa, Saida,
Kietz, Silke,
Jakob, Marcus,
Sommer, Gunhild ,
Heise, Tilman ,
Hundsdörfer, Patrick,
Kühnle, Ingrid,
Dilloo, Dagmar,
Schönberger, Stefan,
Schwabe, Georg,
von Luettichau, Irene,
Graf, Norbert,
Schlegel, Paul-Gerhardt,
Frühwald, Michael,
Jorch, Norbert,
Paulussen, Michael,
Schneider, Dominik T.,
Metzler, Markus,
Leipold, Alfred,
Nathrath, Michaela,
Imschweiler, Thomas,
Christiansen, Holger,
Schmid, Irene,
Crazzolara, Roman,
Niktoreh, Naghmeh,
Cario, Gunnar,
Faber, Joerg,
Demmert, Martin,
Babor, Florian,
Fröhlich, Birgit,
Bielack, Stefan,
Bernig, Toralf,
Greil, Johann,
Eggert, Angelika,
Simon, Thorsten and
Foell, Juergen
(2024)
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
The Lancet Oncology 25 (7), pp. 922-932.
This list was generated on Thu Nov 7 06:42:58 2024 CET.